Trademark Details For PHARMING (Serial Number 87093151)

  •  Home
  •  Print
PHARMING
1
1
1
0
Serial Number  United States - USPTO 87093151
Registration Number 5154895
Mark
PHARMING
Filing Date Jul-05-2016
Status
Registered  
SECTION 8 & .. (702)
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Attorney Name
TTAB
0
Action Tags
  



  • Description Of Mark:
  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active


26.07.21
26.07.28
26.09.21



Correspondences

NameMark D. Passler AKERMAN LLP
Address777 S. Flagler Drive Suite 1100, West Tower West Palm Beach, FL 33401 UNITED STATES

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jul-08-2016NEW APPLICATION ENTERED   NWAPI
Jul-09-2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jul-12-2016NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Oct-13-2016ASSIGNED TO EXAMINER   DOCKD
Oct-18-2016EXAMINERS AMENDMENT -WRITTEN   CNEAR
Oct-18-2016EXAMINERS AMENDMENT E-MAILED   GNEAF
Oct-18-2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED   GNENO
Oct-18-2016EXAMINER'S AMENDMENT ENTERED   XAECI
Oct-18-2016APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Nov-03-2016ASSIGNED TO LIE   ALIEA
Nov-03-2016LAW OFFICE PUBLICATION REVIEW COMPLETED   PREVO
Nov-16-2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Dec-06-2016PUBLISHED FOR OPPOSITION   PUBOA
Dec-06-2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jan-24-2017TEAS DELETE 1(B) BASIS RECEIVED   D1BRI
Jan-31-2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Jan-31-2017NOTICE OF ALLOWANCE CANCELLED   IUCNS
Feb-02-20171(B) BASIS DELETED; PROCEED TO REGISTRATION   DP1BI
Mar-07-2017REGISTERED-PRINCIPAL REGISTER   R.PRA
Mar-07-2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Dec-09-2022NOTICE OF SUIT   NOSUI
Feb-20-2023TEAS SECTION 8 & 15 RECEIVED   E815I
Mar-14-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Mar-14-2023
OFFICE ACTION ISSUED POU1
  
PUM1O
Apr-18-2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED   EROPI
May-23-2023
PROOF OF USE INTERIM ACTION ISSUED
  
PUMIO
Sep-27-2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED   EROPI
Oct-27-2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Oct-28-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E
Jan-16-2024NOTICE OF SUIT   NOSUI